- Home
- RNAZ vs SPHL Comparison
RNAZ vs SPHL Comparison
Compare RNAZ & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNAZ | SPHL |
|---|---|---|
| Founded | 2016 | 2002 |
| Country | United States | Singapore |
| Employees | N/A | 73 |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 5.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNAZ | SPHL |
|---|---|---|
| Price | $4.90 | $2.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 44.4K | ★ 2.1M |
| Earning Date | 04-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.82 | $0.35 |
| 52 Week High | $20.99 | $25.11 |
Technical Indicators
Market Signals| Indicator | RNAZ | SPHL |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 46.36 |
| Support Level | $3.82 | $2.24 |
| Resistance Level | $6.15 | $3.08 |
| Average True Range (ATR) | 0.67 | 0.83 |
| MACD | 0.04 | -0.11 |
| Stochastic Oscillator | 50.77 | 8.24 |
Price Performance
Historical ComparisonAbout RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
About SPHL Springview Holdings Ltd Class A Ordinary Shares
Springview Holdings Ltd conducts its operations through its indirect wholly-owned subsidiary, which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of work, including new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment in the development of construction projects. It derives maximum revenue from its Residential Customers.